Table 1.
Gene expression in the brain 3 d after strokea
| Vehicle |
Daidzein |
||||
|---|---|---|---|---|---|
| Contralateral | Ipsilateral | Contralateral | Ipsilateral | ||
| Pparγ | = | 1.20E-03 ± 9.9E-05 | 0.52E-03 ± 6.0E-05b | 1.41E-03 ± 12.4E-05 | 0.69E-03 ± 16.4E-05b |
| Lxr | ⇑ | 1.90E-03 ± 9.7E-05 | 2.20E-03 ± 7.1E-05b | 2.12E-03 ± 6.3E-05 | 2.58E-03 ± 7.7E-05b,c |
| Scarb1 | = | 1.83E-03 ± 1.1E±04 | 4.79E-03 ± 2.7E-04b | 1.57E-03 ± 2.3E-04 | 4.08E-03 ± 6.2E-04b |
| Ldlr | = | 5.63E-03 ± 7.5E-04 | 4.03E-03 ± 4.9E-04 | 5.44E-03 ± 8.0E-04 | 3.84E-03 ± 5.3E-04 |
| Abcg1 | = | 7.32E-03 ± 6.1E-04 | 4.74E-03 ± 4.6E-04b | 9.00E-03 ± 7.2E-04 | 5.82E-03 ± 6.7E-04b |
| Abca1 | = | 7.28E-03 ± 3.5E-04 | 9.77E-03 ± 3.7E-04b | 7.07E-03 ± 1.8E-04 | 10.07E-03 ± 4.6E-04b |
| Apoe | ⇑ | 7.61E-01 ± 3.3E-02 | 5.17E-01 ± 1.5E-02b | 8.97E-01 ± 3.7E-02d | 6.27E-01 ± 4.6E-02b,c |
| Lrp1 | = | 8.99E-02 ± 7.5E-03 | 6.61E-02 ± 5.5E-03b | 9.52E-02 ± 2.9E-03 | 7.06E-02 ± 6.5E-03 |
| Synaptophysin | = | 2.38E-01 ± 1.1E-02 | 0.92E-01 ± 1.2E-02b | 2.70E-01 ± 1.7E-02 | 1.44E-01 ± 2.7E-02b |
| Gap-43 | = | 7.61E-02 ± 3.0E-03 | 3.77E-02 ± 4.1E-03b | 7.85E-02 ± 4.4E-03 | 4.45E-02 ± 5.5E-03b |
| Psd-95 | = | 1.50E-01 ± 1.2E-02 | 0.51E-01 ± 0.7E-02b | 1.47E-01 ± 1.3E-02 | 0.73E-01 ± 1.1E-02b |
| Gfap | = | 2.57E-01 ± 1.7E-02 | 3.77E-01 ± 1.9E-02b | 1.93E-01 ± 5.0E-02 | 4.00E-01 ± 4.5E-02b |
aData are mean ± SEM. = and ⇑ indicate no and significant gene changes in the ipsilateral hemisphere by daidzein treatment.
bp < 0.05 versus contralateral (two-way ANOVA and post hoc Newman-Keuls test); n = 5 or 6.
cp < 0.05 versus ipsilateral of vehicle (two-way ANOVA and post hoc Newman-Keuls test); n = 5 or 6.
dp < 0.05 versus contralateral of vehicle (two-way ANOVA and post hoc Newman-Keuls test); n = 5 or 6.